Rainbow Children's Medicare Limited (RAINBOW) Earnings Call Transcripts

9 earnings calls from August 2024 to July 31, 2026

NSEI IN Health Care Health Care Providers and Services

Rainbow Children's Medicare Limited's Latest Earnings Call - Q4 FY2026

In Q4 FY '26, Rainbow Children's Medicare Limited reported a significant revenue increase of 24% year-over-year, totaling INR 459.9 crores, alongside a 38% rise in profit after tax (PAT) to INR 78.2 crores. The company achieved its highest ever quarterly revenue, driven by strong operational metrics, including a 20% growth in inpatient discharges and stable occupancy rates despite substantial bed additions. Management has guided for a continued growth target of 20% for FY '27, indicating confidence in maintaining momentum and improving clinical outcomes.

Reported metrics

MetricValueContext
Revenue INR 459.9 crores (beat) vs INR 370.3 crores est, +24% YoY
PAT INR 78.2 crores (beat) vs INR 56.6 crores est, +38% YoY
EBITDA INR 144.7 crores (beat) vs INR 115.0 crores est, +26% YoY
EBITDA Margin 31.5% (inline) vs 31.0% est, inline
Occupancy Rate 45.3% (negative) vs 50% est, decline due to seasonal factors
Cash Position INR 594 crores (positive) Healthy liquidity position for expansions

Guidance from management

Management has guided for a growth target of 20% for FY '27, emphasizing a focus on improving occupancy and clinical excellence across the network.

What management said

Yes. So I think to answer your first question, operationally, we're getting a lot of tech into place. We are getting a new CRM sort we're working on. I think at this point, Rainbow has a lot of leads which come in because of the various activities we do well. And we are centering our operational capabilities to convert these leads. So one is tech. That is going to be largely play a large role in strengthening option ...
— Abrarali Dalal, Q4 FY2026 earnings call
It's a great question. Actually, if you look at our balance sheet, we have been a cash-rich company. So we don't have any debt in our book right now. Our balance sheet has close to INR 700 crore cash right now while we speak. And whatever the CapEx we have done so far has been funded through internal accruals. Whatever the pipelines we have of close to 900 beds, which we have just announced in our presentation, all w...
— Vikas Maheshwari, Q4 FY2026 earnings call

What analysts pressed on

Analysts expressed concerns regarding the declining occupancy rates in mature hospitals and the impact of seasonal fluctuations on performance. There were also inquiries about the sustainability of growth in the IVF segment and the effectiveness of digital initiatives in driving patient volumes.

Main topics on the call

Read the full Rainbow Children's Medicare Limited transcript (Q4 FY2026) → Summary generated from the call transcript; every figure above is stated by management on the record.

About Rainbow Children's Medicare Limited

Rainbow Children's Medicare Limited (RAINBOW) is a publicly listed company in the Health Care Providers and Services industry, within the Health Care sector. It trades on NSEI and is based in IN. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 9 calls on record spanning August 14, 2024 to July 31, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.

Earnings Call History

EarningsCalls.dev has 9 Rainbow Children's Medicare Limited earnings call transcripts on record, spanning August 14, 2024 to July 31, 2026. Based on this history, Rainbow Children's Medicare Limited reports quarterly. The most recent call on file is dated July 31, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker
RAINBOW
Exchange
NSEI
Country
IN
Sector
Health Care
Industry
Health Care Providers and Services
Calls on record
9
First call
August 14, 2024
Most recent
July 31, 2026
Reporting cadence
quarterly
Quarter Date
Q1 FY2027 Jul 31, 2026 Read transcript
Q4 FY2026 May 25, 2026 Read transcript
Q3 FY2026 Jan 29, 2026 Read transcript
Q2 FY2026 Nov 14, 2025 Read transcript
Q1 FY2026 Jul 28, 2025 Read transcript
Q4 FY2025 May 26, 2025 Read transcript
Q3 FY2025 Feb 10, 2025 Read transcript
Q2 FY2025 Oct 28, 2024 Read transcript
Q1 FY2025 Aug 14, 2024 Read transcript